CohBar's Unattributed - II Round

CohBar raised a round of funding on February 20, 2014.

CohBar is a biotechnology company whose mission is to treat age-related diseases and extend healthy life span through the discovery of novel mitochondrial-derived peptides ("MDPs") and the advancement…

Articles about CohBar's Unattributed - II Round: